Transcription of Protocol Version Date: April13, 2021 DF/HCC Protocol
{{id}} {{{paragraph}}}
Example: air traffic controller
Protocol Version Date: April13, 2021 DF/HCC Protocol
DFCI Protocol 16-001PI: Lewis Silverman, MDVersion: April 13, 20211 Protocol Version Date: April13, 2021DF/HCC Protocol #: 16-001 IND Status: Not applicable TITLE: Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and AdolescentsCoordinating Center: Dana-Farber/Boston Children s Cancer and Blood Disorders Center Principal Investigator (PI): Lewis Silverman, MD, Dana-Farber Cancer Institute DFCI/BCH Collaborating Investigators Kira Bona, MD (Dana-Farber/Boston Children s Hospital) Melissa Burns, MD (Dana-Farber/Boston Children s Hospital) Kimberly Davies, MD (Dana-Farber/Boston Children s Hospital) Barbara Degar, MD (Dana-Farber/Boston Children s Hospital) Alejandro Gutierrez, MD (Dana-Farber/Children s Hospital) Marian Harris, MD, PhD (Boston Children s Hospital) Jennifer Kesselheim, MD (Dana-Farber/Boston Children s Hospital) Birgit Knoechel, MD, PhD (Dana-Farber/Boston Children s Hospital) Yana Pikman, MD (Dana-Farber/Boston Children s Hospital) Andrew Place, MD, PhD (Dana-Farber/Boston Children s Hospital) Jessica Pollard, MD (Dana-Farber/Boston Children s Hospital) Stephen E.
DFCI Protocol 16-001 PI: Lewis Silverman, MD Version: April 13, 2021 3 Meghan Dens, RN, BSN, Dana-Farber Cancer Institute 450 Brookline Ave, SW463
Loading..
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: